Steven Rodems
Papers
1
Total Citations
160
H-Index
1
About
Steven Rodems is a distinguished biochemist and drug discovery scientist whose work has significantly advanced the field of high-throughput screening for protein kinases and phosphatases. His key research focuses on developing innovative assay technologies to probe cellular signaling pathways, particularly those governing cell proliferation, apoptosis, and metabolism. Rodems’s most impactful contribution is his pioneering development of a FRET-based assay platform for ultra-high density drug screening, detailed in his highly cited 2002 paper (160 citations). This work revolutionized the ability to rapidly and sensitively identify modulators of kinase and phosphatase activity, which are central to many diseases, including cancer. By enabling the efficient interrogation of these critical regulatory enzymes, Rodems’s platform has become a cornerstone in early-stage drug discovery, accelerating the search for targeted therapeutics. His achievements underscore a career dedicated to bridging fundamental biochemical mechanisms with practical, high-impact screening solutions that continue to shape the pharmaceutical landscape.
Research Focus
Key Achievements
Top Papers
- 1